No evidence of histology subtype-specific prognostic signatures among lung adenocarcinoma and squamous cell carcinoma patients at early stages
Suyan Tian, Chi Wang, Ming-Wen An

TL;DR
This study used a simple Cox regression-based feature selection method on microarray data and found no evidence of histology-specific prognostic gene signatures in early-stage lung adenocarcinoma and squamous cell carcinoma.
Contribution
The paper introduces a straightforward feature selection algorithm that challenges the existence of histology-specific prognostic signatures in early-stage NSCLC.
Findings
No histology-specific prognostic gene signatures were identified.
A 31-gene prognostic signature was found with comparable performance to existing signatures.
The proposed method is simple, easy to implement, and adaptable for other research hypotheses.
Abstract
Background Non-small cell lung cancer (NSCLC) is the predominant histological type of lung cancer, accounting for up to 85% of cases. Disease stage is commonly used to determine adjuvant treatment eligibility of NSCLC patients, however, it is an imprecise predictor of the prognosis of an individual patient. Currently, many researchers resort to microarray technology for identifying relevant genetic prognostic markers, with particular attention on trimming or extending a Cox regression model. Among NSCLC, adenocarcinoma (AC) and squamous cell carcinoma (SCC) are two major histology subtypes. It has been demonstrated that there exist fundamental differences in the underlying mechanisms between them, which motivated us to postulate there might exist specific genes relevant to prognosis of each histology subtype. Results In this article, we propose a simple filterer feature…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGene expression and cancer classification · Cancer-related molecular mechanisms research · Bioinformatics and Genomic Networks
